SCHEMBL13638986

SCHEMBL13638986

COCc1ccc(C(=O)NC[C@@H]2CCCO2)c(NC(=O)c2coc(N3CCC(Oc4ncccn4)CC3)n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
MAPT P10636 2/20 0.41
ALDH1A1 P00352 6/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 3/20 0.40
LMNA P02545 1/20 0.40
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 4/20 0.39
GAA P10253 4/20 0.39
MEN1 O00255 2/20 0.39
CASP1 P29466 2/20 0.39
CASP7 P55210 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638901 1.00 KMT2A (0.42) KMT2ACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL13634611 0.93 POLB (0.42) KMT2ACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL13634610 0.93 POLB (0.42) KMT2ACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL13634675 0.86 PDE10A (0.48) KMT2ACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL13634542 0.85 POLB (0.44) KMT2ACYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL13638812 0.85 GPR6 (0.39) NPC1RAB9A
SCHEMBL13634670 0.78 PARP1 (0.38) KMT2AMEN1
SCHEMBL13638762 0.76 PDE10A (0.40) MAPTALDH1A1HPGDKDM4EAXL
SCHEMBL13634801 0.76 CNR1 (0.46) CYP2C9CYP2C19MAPT
SCHEMBL13270762 0.75 S1PR1 (0.40) SMN1; SMN2TSHRMAPK1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304547-B2 Azolecarboxamide compound or salt thereof ASTELLAS PHARMA INC. (JP) 2012-11-06 US disclosed